Location History:
- Hsi-Chih, TW (2009)
- His-Chih, TW (2010 - 2013)
- New Taipei, TW (2017 - 2018)
Company Filing History:
Years Active: 2009-2025
Title: Yi-Wen Chu: Innovator in Pharmaceutical Formulations
Introduction
Yi-Wen Chu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceutical formulations, particularly in enhancing drug solubility and absorption. With a total of 6 patents to his name, his work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of Yi-Wen Chu's latest patents focuses on formulations with enhanced SN-38 solubility and oral absorption. This innovative formulation comprises 7-Ethyl-10-hydroxy-camptothecin (SN-38) and a mixture of pharmaceutically acceptable excipients, including N-Methylpyrrolidone and Vitamin E TPGS. The composition is designed to be in a liquid or gel form, ensuring that SN-38 is dissolved without precipitation. Another significant patent involves compositions for treating inflammatory bowel diseases and intestinal colitis. This composition includes a therapeutically effective amount of an anthraquinone derivative, such as diacerein, combined with a pharmaceutically acceptable vehicle.
Career Highlights
Throughout his career, Yi-Wen Chu has worked with various companies, including Sunten Phytotech Co., Ltd. and Tairx, Inc. His expertise in pharmaceutical formulations has positioned him as a key player in the industry, contributing to advancements in drug delivery systems.
Collaborations
Yi-Wen Chu has collaborated with notable colleagues, including Du-Shieng Chien and Wu-Chang Chuang. These partnerships have fostered innovation and development in the field of pharmaceuticals.
Conclusion
Yi-Wen Chu's contributions to pharmaceutical formulations demonstrate his commitment to improving drug efficacy and patient outcomes. His innovative patents and collaborations highlight his role as a leading inventor in the industry.